Sanofi India declined 2.63% to Rs 6,430.40 after the companys net profit fell 32.5% to Rs 120.40 crore on 11.4% decrease in net sales to Rs 699.30 crore in Q2 CY22 over Q2 CY21.
The key equity benchmarks were currently trading near the days high in mid-morning trade. The Nifty hovered near the 16,500 mark. Pharma stocks witnessed some bit of value buying after declining in the past four sessions. Buzzing Index: The Nifty Pharma index rose 1.30% to 12,502. The index had declined 2.91% in the past four sessions. Laurus Labs (up 2.56%), Zydus Lifesciences (up 2.29%), Divis […]
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
